(redirected from Vitrasert)
Also found in: Medical.
Related to Vitrasert: ganciclovir implant


 (găn-sī′klō-vîr′, -klə-)
A synthetic nucleoside analog, C9H13N5O4, derived from guanine and used in the prevention and treatment of opportunistic cytomegalovirus infections.

[gan-, origin unknown + -ciclovir, antiviral drug suffix (from acyclovir).]


n ganciclovir m
References in periodicals archive ?
pSivida also has two products approved by the Food and Drug Administration (FDA): Retisert for the treatment of uveitis and Vitrasert for the treatment of AIDS-related cytomegalovirus (CMV) retinitis.
We suggest that BOL's proprietary treatment solutions in this area -- highlighted by the Vitrasert technology -- would promulgate a long-term payoff for the company.
foldable intraocular lenses (IOLs); and the Vitrasert Implant, the first
Its product portfolio includes microkeratomes and blades for LASIK refractive surgery; an advanced excimer laser with a built-in LASIK workstation for refractive surgery; equipment and viscoelastics for cataract surgery; PMMA and foldable intraocular lenses (IOLs); and the Vitrasert Implant, the first drug delivery system to provide local, sustained therapy for the treatment of cytomegalovirus retinitis (CMV) in people with AIDS.
Participants were randomly assigned to one of three trial arms: Vitrasert (ganciclovir implant) and CYTOVENE capsules (1500 mg tid**): Vitrasert and oral placebo; or CYTOVENE-I.
Hoffmann-La Roche, a research-based health care company, has a long history in the area of HIV that includes Invirase, Hivid, Cytovene, Vitrasert (Vitrasert is a trademark of Chiron Vision), Roferon-A and Bactrim.